Submitted by web@researchtop... on Tue, 06/29/2010 - 12:45
Bevacizumab in the Primary Treatment of Advanced Ovarian, Peritoneal or Fallopian Tube Carcinoma
| CME test | Downloadable PDF | PowerPoint slides | CME Information and Faculty Disclosures |
| Read Dr Love's original email (from June 30, 2010) | Subscribe to Dr Love's email alerts | ||
Transcribed comments from recent interviews with Robert A Burger, MD (6/16/10), Robert L Coleman, MD (6/21/10), Thomas J Herzog, MD (6/21/10), Ursula A Matulonis, MD (6/16/10) and David R Spriggs, MD (6/23/10) about a presentation at ASCO 2010
Burger RA et al. Phase III trial of bevacizumab in the primary treatment of advanced epithelial ovarian, primary peritoneal or fallopian tube cancer: A Gynecologic Oncology Group (GOG) study. Proc ASCO 2010;Abstract LBA1.